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NEGATIVE TRIALS IN PSYCHOSIS PREVENTION: THE NEGLECTED 
IMPORTANCE OF PRETEST RISK ENRICHMENT 
Dear Editor 
In the wake of the recently published ω-3 polyunsaturated fatty acids multisite trial 
(NEURAPRO) in the journal (McGorry et al, n=3041), the three largest studies of 
preventative interventions in individuals at ultra high risk (UHR) for psychosis have 
turned out to be negative (Morrison et al, n=2882, McFarlane et al, n=2923), 
suggesting that it may not currently be possible to prevent psychosis. However, the 
actual risk of psychosis in these interventional studies was found to be extremely low, 
even in the control group (11.2% in McGorry et al at 1y1, 9% at 2y in Morrison et al 
and 2.3% at 2y in McFarlane et al 3, implying that these negative findings are likely to 
be secondary to small statistical power.  
 
On a conceptual level, these studies challenge the underlying assumption that it is 
acceptable to meet specific psychometric criteria at intake to be slotted into the UHR 
category. Actually, the predictive power of the UHR criteria is not fixed priority, but 
is strongly dependent on the risk enrichment of the samples to which they are applied 
(i.e. “pretest” risk)4. This is due to the psychometric characteristics of these UHR 
instruments: they are good to rule out psychosis, but only moderately useful to rule in 
psychosis4. Therefore, majority of the observed risk to psychosis is not gained 
through UHR assessment per se, but is obtained before the assessment (pretest phase) 
during the recruitment of these individuals. Pretest risk enrichment in samples 
undergoing an UHR assessment remains substantial (15% at 38 months) and highly 
heterogeneous (9%-24% at 38 months)4. Pretest risk enrichment is modulated by the 
type of recruitment strategies adopted to select individuals for UHR assessment4. For 
example, recruiting individuals who were already filtered by adult mental health 
services is associated with higher pretest risk enrichment, as compared to recruiting 
individuals through intensive community outreach5. Not surprisingly, the lowest 
transition risk was reported in McFarlane et al, that has adopted a strong “community 
outreach and education program aimed at teachers, school, and college counsellors”3. 
Due to the heightened pressure to recruit participants into interventional studies, it is 
possible that a substantial proportion of these samples had been recruited through 
community outreach, diluting the transition risks.  
 
It therefore seems expedient to control the pretest risk enrichment of samples 
recruited into future interventional studies for psychosis prevention by using pretest 
risk stratification models that have been recently validated in this journal5.  
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